|
HY-100817-5mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100817-50mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100978-10mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-100978-100mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-100978-25mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-100978-5mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-100978-50mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-101082-10mg
|
MedChemexpress LLC
|
N6,2′-O-Dimethyladenosine [CAS 57817-83-1]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101082-5mg
|
MedChemexpress LLC
|
N6,2′-O-Dimethyladenosine [CAS 57817-83-1]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101125-10mg
|
MedChemexpress LLC
|
L-Moses [CAS 2079885-05-3]
|
|
Cancer-programmed cell death
|
|
|
HY-101125-5mg
|
MedChemexpress LLC
|
L-Moses [CAS 2079885-05-3]
|
|
Cancer-programmed cell death
|
|
|
HY-101290A-10mg
|
MedChemexpress LLC
|
BMT-090605 (hydrochloride) [CAS 2231664-45-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101290A-100mg
|
MedChemexpress LLC
|
BMT-090605 (hydrochloride) [CAS 2231664-45-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101290A-25mg
|
MedChemexpress LLC
|
BMT-090605 (hydrochloride) [CAS 2231664-45-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101290A-5mg
|
MedChemexpress LLC
|
BMT-090605 (hydrochloride) [CAS 2231664-45-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101290A-50mg
|
MedChemexpress LLC
|
BMT-090605 (hydrochloride) [CAS 2231664-45-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101464-10mg
|
MedChemexpress LLC
|
ML329 [CAS 19992-50-8]
|
|
|
|
|
HY-101464-100mg
|
MedChemexpress LLC
|
ML329 [CAS 19992-50-8]
|
|
|
|
|
HY-101464-25mg
|
MedChemexpress LLC
|
ML329 [CAS 19992-50-8]
|
|
|
|
|
HY-101464-5mg
|
MedChemexpress LLC
|
ML329 [CAS 19992-50-8]
|
|
|
|
|
HY-101464-50mg
|
MedChemexpress LLC
|
ML329 [CAS 19992-50-8]
|
|
|
|
|
HY-101528-100mg
|
MedChemexpress LLC
|
IDRA 21 [CAS 22503-72-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101528-50mg
|
MedChemexpress LLC
|
IDRA 21 [CAS 22503-72-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101535-5mg
|
MedChemexpress LLC
|
ARP101 [CAS 849773-63-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101597-10mg
|
MedChemexpress LLC
|
NVX-207 [CAS 745020-66-0]
|
|
Cancer-programmed cell death
|
|
